0001493152-21-023101.txt : 20210920
0001493152-21-023101.hdr.sgml : 20210920
20210920083022
ACCESSION NUMBER: 0001493152-21-023101
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210914
FILED AS OF DATE: 20210920
DATE AS OF CHANGE: 20210920
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: AJJARAPU SURENDRA K
CENTRAL INDEX KEY: 0001368298
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40793
FILM NUMBER: 211262107
MAIL ADDRESS:
STREET 1: 8604 BUTTON BUSH CT
CITY: TAMPA
STATE: FL
ZIP: 33647
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aesther Healthcare Acquisition Corp.
CENTRAL INDEX KEY: 0001869974
STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770]
IRS NUMBER: 871309280
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 515 MADISON AVE SUITE 8078
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: (646) 908-2658
MAIL ADDRESS:
STREET 1: 515 MADISON AVE SUITE 8078
CITY: NEW YORK
STATE: NY
ZIP: 10022
3
1
ownership.xml
X0206
3
2021-09-14
0
0001869974
Aesther Healthcare Acquisition Corp.
AEHA
0001368298
AJJARAPU SURENDRA K
515 MADISON AVENUE,
SUITE 8078
NEW YORK
NY
10022
1
1
1
0
Chief Executive Officer
Class B common stock
Class A common stock
2875000
I
See footnote
As described in the issuer's registration statement on Form S-1 (File No. 333- 258012) under the heading "Description of Securities," the shares of Class B common stock of the issuer will automatically convert into shares of Class A common stock of the issuer at the time of the issuer's initial business combination, on a one-for-one basis, subject to certain adjustments described therein, and have no expiration date.
These shares represent 2,875,000 shares of Class B common stock of the issuer held by Aesther Healthcare Sponsor, LLC (the "Sponsor"), including an aggregate of up to 375,000 shares subject to forfeiture by the Sponsor to the extent that the underwriter's over-allotment is not exercised in full or in part (provided that a portion of such over-allotment has already been exercised and as such only 250,000 shares remain subject to forfeiture).
Suren Ajjarapu is the managing member of the Sponsor and Chief Executive Officer of the Issuer. As such, the Reporting Person may be deemed to have beneficial ownership of such shares. Mr. Ajjarapu disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly.
/s/ Suren Ajjarapu
2021-09-17